These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11891102)

  • 101. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Safety of rapid intravenous valproate infusion in pediatric patients.
    Morton LD; O'Hara KA; Coots BP; Pellock JM
    Pediatr Neurol; 2007 Feb; 36(2):81-3. PubMed ID: 17275657
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Diabetic ketoacidosis with severe hypokalaemia and valproate-associated Fanconi syndrome.
    Morton A
    Intern Med J; 2023 Jan; 53(1):155-156. PubMed ID: 36693648
    [No Abstract]   [Full Text] [Related]  

  • 104. Valproic acid as an adjuvant analgesic: adult Fanconi syndrome.
    Maybach A; Baro S; Kachurka K; Davis MP
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e942-e944. PubMed ID: 35764376
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Association of Familial Fanconi Syndrome with a Novel GATM Variant.
    Kudo H; Suzuki R; Kondo A; Nozu K; Nakamura Y; Mikami H; Soma J; Nakaya I
    Tohoku J Exp Med; 2023 Aug; 260(4):337-340. PubMed ID: 37286521
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Parkinsonian syndrome in childhood after sodium valproate administration.
    Alvarez-Gomez MJ; Vaamonde J; Narbona J; Barao M; Barona P; Brannan T; Gudin M; Ibañez R
    Clin Neuropharmacol; 1993 Oct; 16(5):451-5. PubMed ID: 8221706
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Kidney tubular injury induced by valproic acid: systematic literature review.
    Anguissola G; Leu D; Simonetti GD; Simonetti BG; Lava SAG; Milani GP; Bianchetti MG; Scoglio M
    Pediatr Nephrol; 2023 Jun; 38(6):1725-1731. PubMed ID: 36645492
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Drug-induced interstitial nephritis as a result of sodium valproate and triamterene.
    Aghsaeifard Z; Alizadeh R
    Urol Case Rep; 2020 Nov; 33():101329. PubMed ID: 33102031
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report.
    Kita Y; Shirai S; Koyama T; Makinouchi R; Machida S; Matsui K; Koike J; Imai N
    CEN Case Rep; 2024 Jul; ():. PubMed ID: 38955949
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.
    Wang C; Zhou Y; Song L; Deng Z; Fang W
    Front Med (Lausanne); 2022; 9():945244. PubMed ID: 36186816
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Renal toxicity induced by valproic acid (Depakene).
    Hawkins E; Brewer E
    Pediatr Pathol; 1993; 13(6):863-8. PubMed ID: 8108303
    [No Abstract]   [Full Text] [Related]  

  • 112. Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome.
    Yoshida T; Tsujimoto H; Ichikawa T; Kounami S; Suzuki H
    Case Rep Oncol; 2018; 11(1):63-67. PubMed ID: 29515412
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Rare case of interstitial nephritis in a young adult under IgG therapy.
    Figueiredo AC; Nunes I; Ferreira E; Faria E
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35110283
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Correction to: Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report.
    Kita Y; Shirai S; Koyama T; Makinouchi R; Machida S; Matsui K; Koike J; Imai N
    CEN Case Rep; 2024 Aug; ():. PubMed ID: 39133393
    [No Abstract]   [Full Text] [Related]  

  • 115. A dilemma of proximal tubule in an infant: hypophosphatemia and hypouricemia without hypokalemia and acidosis: Answers.
    Soyaltın E; Demir BK; Erfidan G; Çamlar SA; Alaygut D; Mutlubaş F
    Pediatr Nephrol; 2020 Apr; 35(4):611-613. PubMed ID: 31900631
    [No Abstract]   [Full Text] [Related]  

  • 116. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Renal injury from valproic acid: case report and literature review.
    Zaki EL; Springate JE
    Pediatr Neurol; 2002 Oct; 27(4):318-9. PubMed ID: 12435575
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.